Gossamer Bio Inc. (goss 5 06/01/27)
13F holders, Q1 2026 (March 31)1holders
1new positions
1sold out
$0.39avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Gossamer Bio Inc. (goss 5 06/01/27) in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 1 sold out. The largest holder was Monashee Investment Management LLC ($845K).
- Company
- Gossamer Bio Inc. (goss 5 06/01/27)
- CUSIP
- 38341PAA0
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $845K |
| Exits | 1 | $5.5M |
All 13F filers, Q4 2025 → Q1 2026: 2,167,000 shares bought and 8,000 shares sold, net +2,159,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Monashee Investment Management LLC | 0.55% | New | 2,167,000 | $845K |
"% of holder's portfolio" is GOSSAMER BIO INC (GOSS 5 06/01/27)'s weight in each manager's 13F, not the share of Gossamer Bio Inc. (goss 5 06/01/27) the manager owns.